It’s a decision that millions of people affected by Alzheimer’s disease and their families have been waiting for—the first fully approved drug that treats the disease, rather than its symptoms. On July 6, the U.S. Food and Drug Administration (FDA) granted full approval for lecanemab, or Leqembi, to treat Alzheimer’s in people in the early, mild stages of the neurodegene…
Read more“I actually only started wearing the hijab one year ago,” said Shehadeh, an undergraduate studying math and economics at Fordham University in New York.”I always wanted to, but I wasn’t ready. It was actually during Ramadan last year, one week before Eid that I had this feeling to wear the hijab.”
Shehadeh, a Palestinian-American, was with her two sisters, Shireen, 26, and Nisrien, 18, an…
Read more